Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

PAED EuroNet-PHL-C2, DECOPDAC-21, Hodgkin Lymphoma

Protocol-ID: 1239 V1.0 (Mini), PAED EuroNet-PHL-C2, DECOPDAC-21, Hodgkin
Study protocol, available to authorized participants only.

Indication(s)

  • Hodgkin Lymphoma; ICD-10 C81.-

Links

  • Studie EuroNet-PHL-C2, the trial is an international, multicentre, randomised controlled trial with the aims to reduce the indication for radiotherapy in newly diagnosed patients with classical Hodgkin lymphoma without compromising cure rates and to investigate a chemotherapy intensification randomisation in intermediate and advanced classical Hodgkin lymphoma to compensate for reduction in radiotherapy. [clinicaltrials.gov]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 20.10.2021